Cargando…
A picture of the covid-19 impact on IVIRMA fertility treatment clinics in Spain and Italy
The emergence of the novel coronavirus infection that arose in Wuhan, China in December 2019 has resulted in an epidemic that has quickly expanded to become one of the most significant public health threats in recent times. Unfortunately, the disease has spread globally. On March 11th (2020) World H...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Reproductive Healthcare Ltd. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194545/ https://www.ncbi.nlm.nih.gov/pubmed/32451301 http://dx.doi.org/10.1016/j.rbmo.2020.04.015 |
_version_ | 1783528359844642816 |
---|---|
author | Requena, Antonio Cruz, María Vergara, Vanessa Prados, Nicolás Galliano, Daniela Pellicer, Antonio |
author_facet | Requena, Antonio Cruz, María Vergara, Vanessa Prados, Nicolás Galliano, Daniela Pellicer, Antonio |
author_sort | Requena, Antonio |
collection | PubMed |
description | The emergence of the novel coronavirus infection that arose in Wuhan, China in December 2019 has resulted in an epidemic that has quickly expanded to become one of the most significant public health threats in recent times. Unfortunately, the disease has spread globally. On March 11th (2020) World Health Organization (WHO) declared Covid-19 a pandemic and has called governments to take urgent and aggressive action to change the course of the outbreak. Within the context of Assisted Reproduction, both reproductive medicine professionals and patients are also fighting against this unprecedented viral pandemic. In view of events, most of us had to make serious decisions, some of them with a lack of scientific evidence due to the circumstances and with the only objective of ensuring the safe care of our patients, reduce non-essential contacts and prevent possible maternal and fetal complications in future pregnancies. Pregnant women should not be considered at high risk for developing severe infection. Up to date, there are no reported deaths in pregnant women with Covid-19, while in the cases that have presented pneumonia because of Covid-19, the symptoms have been moderate and with a good prognosis in recovery |
format | Online Article Text |
id | pubmed-7194545 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Reproductive Healthcare Ltd. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71945452020-05-02 A picture of the covid-19 impact on IVIRMA fertility treatment clinics in Spain and Italy Requena, Antonio Cruz, María Vergara, Vanessa Prados, Nicolás Galliano, Daniela Pellicer, Antonio Reprod Biomed Online Commentary The emergence of the novel coronavirus infection that arose in Wuhan, China in December 2019 has resulted in an epidemic that has quickly expanded to become one of the most significant public health threats in recent times. Unfortunately, the disease has spread globally. On March 11th (2020) World Health Organization (WHO) declared Covid-19 a pandemic and has called governments to take urgent and aggressive action to change the course of the outbreak. Within the context of Assisted Reproduction, both reproductive medicine professionals and patients are also fighting against this unprecedented viral pandemic. In view of events, most of us had to make serious decisions, some of them with a lack of scientific evidence due to the circumstances and with the only objective of ensuring the safe care of our patients, reduce non-essential contacts and prevent possible maternal and fetal complications in future pregnancies. Pregnant women should not be considered at high risk for developing severe infection. Up to date, there are no reported deaths in pregnant women with Covid-19, while in the cases that have presented pneumonia because of Covid-19, the symptoms have been moderate and with a good prognosis in recovery Reproductive Healthcare Ltd. Published by Elsevier Ltd. 2020-07 2020-04-25 /pmc/articles/PMC7194545/ /pubmed/32451301 http://dx.doi.org/10.1016/j.rbmo.2020.04.015 Text en © 2020 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Commentary Requena, Antonio Cruz, María Vergara, Vanessa Prados, Nicolás Galliano, Daniela Pellicer, Antonio A picture of the covid-19 impact on IVIRMA fertility treatment clinics in Spain and Italy |
title | A picture of the covid-19 impact on IVIRMA fertility treatment clinics in Spain and Italy |
title_full | A picture of the covid-19 impact on IVIRMA fertility treatment clinics in Spain and Italy |
title_fullStr | A picture of the covid-19 impact on IVIRMA fertility treatment clinics in Spain and Italy |
title_full_unstemmed | A picture of the covid-19 impact on IVIRMA fertility treatment clinics in Spain and Italy |
title_short | A picture of the covid-19 impact on IVIRMA fertility treatment clinics in Spain and Italy |
title_sort | picture of the covid-19 impact on ivirma fertility treatment clinics in spain and italy |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194545/ https://www.ncbi.nlm.nih.gov/pubmed/32451301 http://dx.doi.org/10.1016/j.rbmo.2020.04.015 |
work_keys_str_mv | AT requenaantonio apictureofthecovid19impactonivirmafertilitytreatmentclinicsinspainanditaly AT cruzmaria apictureofthecovid19impactonivirmafertilitytreatmentclinicsinspainanditaly AT vergaravanessa apictureofthecovid19impactonivirmafertilitytreatmentclinicsinspainanditaly AT pradosnicolas apictureofthecovid19impactonivirmafertilitytreatmentclinicsinspainanditaly AT gallianodaniela apictureofthecovid19impactonivirmafertilitytreatmentclinicsinspainanditaly AT pellicerantonio apictureofthecovid19impactonivirmafertilitytreatmentclinicsinspainanditaly AT requenaantonio pictureofthecovid19impactonivirmafertilitytreatmentclinicsinspainanditaly AT cruzmaria pictureofthecovid19impactonivirmafertilitytreatmentclinicsinspainanditaly AT vergaravanessa pictureofthecovid19impactonivirmafertilitytreatmentclinicsinspainanditaly AT pradosnicolas pictureofthecovid19impactonivirmafertilitytreatmentclinicsinspainanditaly AT gallianodaniela pictureofthecovid19impactonivirmafertilitytreatmentclinicsinspainanditaly AT pellicerantonio pictureofthecovid19impactonivirmafertilitytreatmentclinicsinspainanditaly |